César
Martín Plagaro
Instituto de Investigación Sanitaria Biobizkaia
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biobizkaia (8)
2022
-
Boosting Cholesterol Efflux from Foam Cells by Sequential Administration of rHDL to Deliver MicroRNA and to Remove Cholesterol in a Triple-Cell 2D Atherosclerosis Model
Small, Vol. 18, Núm. 13
-
Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids
Hepatology, Vol. 76, Núm. 6, pp. 1617-1633
-
Pathophysiology of Atherosclerosis
International Journal of Molecular Sciences, Vol. 23, Núm. 6
2021
-
Magnesium accumulation upon cyclin M4 silencing activates microsomal triglyceride transfer protein improving NASH
Journal of Hepatology, Vol. 75, Núm. 1, pp. 34-45
2020
-
Birc6 is associated with vulnerability of carotid atherosclerotic plaque
International Journal of Molecular Sciences, Vol. 21, Núm. 24, pp. 1-13
-
Cholesterol efflux efficiency of reconstituted HDL is affected by nanoparticle lipid composition
Biomedicines, Vol. 8, Núm. 10
-
Liver osteopontin is required to prevent the progression of age-related nonalcoholic fatty liver disease
Aging Cell, Vol. 19, Núm. 8
2019
-
SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer
EBioMedicine, Vol. 40, pp. 406-421